comparemela.com
Home
Live Updates
How GLP-1s tanked and reshaped the medtech stock market : comparemela.com
How GLP-1s tanked and reshaped the medtech stock market
Promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market.
Related Keywords
United States ,
China ,
Boston ,
Massachusetts ,
American ,
Massdevice Medtech ,
Johnson Medtech ,
Kevin Lobo ,
Depuy Synthes ,
Myriam Curet ,
Zimmer Biomet ,
Relievant Medsystems ,
Mike Matson ,
Fukuda Denshi ,
Nihon Kohden ,
Novo Nordisk Wegovy ,
Richard Newitter ,
Medtronic ,
Google ,
Ge Healthcare ,
Barco ,
Needham Co ,
Respironics ,
Caption Health ,
Boston Scientific ,
Novo Nordisk ,
American Heart Association ,
Philips ,
American Diabetes Association ,
Medical Design ,
Medtech Big ,
Dow Jones Industrial ,
Truist Securities ,
David Rescott ,
Intuitive Surgical ,
Surgical Chief Medical Officer ,
Cardiovascular Systems ,
Bigfoot Biomedical ,
Royal Philips ,
Globus Medical ,
Virtual Care Management ,
Mayo Clinic ,
Vscan Air ,
comparemela.com © 2020. All Rights Reserved.